相关实验视频

Updated: Jun 8, 2025

Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?

Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?

Published on: June 13, 2014

智能纳米催化剂调解了 lysosomal 除途径,以协调瘤治疗的放大

Mingliang Pei^1,2, Xin Guan³, De Zhao⁴

¹Department of Medical Ultrasound and Center of Minimally Invasive Treatment for Tumor, Shanghai Tenth People's Hospital, School of Medicine, Tongji University, No. 301 Yan-chang-zhong Road, Shanghai, 200072, PR China.

Materials today. Bio

|November 4, 2024

概括

这项研究引入了一个智能纳米催化剂,TCPP-Cu@MnO_x,通过放大反应性氧物种 (ROS) 生产来增强瘤治疗,克服当前ROS驱动疗法的局限性.

科学领域:

生物医学工程生物医学工程
纳米技术纳米技术
癌症治疗癌症治疗

背景情况:

用于瘤治疗的活性氧物种 (ROS) 生产受到外部因素和溶酶体保留的限制.
目前基于ROS的纳米系统在高效瘤细胞向和治疗疗效方面面临挑战.

研究的目的:

开发一种智能纳米催化剂,TCPP-Cu@MnO_x,用于编程ROS放大.
为了克服溶酶体保留和增强ROS驱动的瘤治疗.

主要方法:

一种酸度解锁的纳米催化剂TCPP-Cu@MnO_x被合成和表征.
该纳米催化剂的设计是为了触发 lysosome驱动疗法并逃脱 lysosomes.
研究了ROS生成机制 (单氧氧,基) 和谷氨酸消耗.

主要成果:

与中性条件 (pH 7.4) 相比,纳米催化剂在酸性条件下 (pH 5.0) 显示出明显更高的单一氧气产量.
启动了溶酶体驱动疗法,导致部分溶酶体死亡和纳米催化剂逃逸.
在细胞质中观察到增强的ROS生成 (单氧氧和基) 和谷氨消耗,从而提高治疗效率.

结论:

使用TCPP-Cu@MnO_x编程的ROS放大策略有效地破坏了溶解体,并增强了瘤治疗.
这种方法提供了一种有希望的方法来克服现有的基于ROS的癌症治疗方法的局限性.

关键词:

Lysosomal 损伤是由于 Lysosomal 损伤导致的.编程的ROS战略是有计划的.瘤治疗疗法瘤治疗没有pH解锁的1O2生成

更多相关视频

Contrast Ultrasound Targeted Treatment of Gliomas in Mice via Drug-Bearing Nanoparticle Delivery and Microvascular Ablation

Contrast Ultrasound Targeted Treatment of Gliomas in Mice via Drug-Bearing Nanoparticle Delivery and Microvascular Ablation

Published on: December 15, 2010

One Minute, Sub-One-Watt Photothermal Tumor Ablation Using Porphysomes, Intrinsic Multifunctional Nanovesicles

One Minute, Sub-One-Watt Photothermal Tumor Ablation Using Porphysomes, Intrinsic Multifunctional Nanovesicles

Published on: September 17, 2013

相关概念视频

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Combination Therapies and Personalized Medicine

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...